Inflammatory Breast Cancer

Inflammatory breast cancer (IBC) is rare, and it can be fast-growing and dangerous.

IBC represents only 2 percent to 4 percent of all breast cancer cases in the United States, but due to its aggressive nature, it represents 10 percent of U.S. breast cancer deaths. Early and accurate inflammatory breast cancer diagnosis and personalized treatment by experts who specialize in IBC can make an important difference.

At the UofL Brown Cancer Center, we treat women with inflammatory breast cancer, both those who have been treated before and those who are newly diagnosed.

Our experts are highly skilled in diagnosing inflammatory breast cancer. Doctors from many disciplines work in teams to customize your treatment, and use the most-advanced techniques and technology. It’s essential to establish a comprehensive and personalized treatment plan for inflammatory breast cancer (IBC) as early as possible. For this reason, our team approach, which brings together experts from many specialties, is extremely important.

We are still learning about inflammatory breast cancer, and recent studies show the best treatment often is based on each cancer’s specific genetic and biological makeup.

Inflammatory breast cancer may also be called:

  • Locally advanced breast cancer
  • Breast carcinoma with dermal lymphatic invasion
  • Inflammatory carcinoma of the breast

As a patient at UofL Brown Cancer Center, you are the focus of some of the most talented and experienced physicians in the region.

Learn more about the physicians treating all types of cancer by visiting the list of cancer types on

Learn more about the types of cancer treated at UofL Brown Cancer Center by visiting

Next Steps

For more information or to make an appointment,
call 502-588-6000